Prognosis and Safety of Neoadjuvant Therapy Plus Surgery versus Upfront Surgery in Patients with Resectable Hepatocellular Carcinoma at CNLC Ib-IIa Stage: A Propensity Score Matching Study.
Xiang B, Xu L, Shan J, Chang R, Ge Q, Wang C, Song J, Chen X, Zhou Q, Chen L
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.